Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
a2E6jd4FdrtsuHZZ